Hydrochloric Acid

Hydrochloric Acid

SCHEMBL204294

CCCCc1nccn1C.Cl

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 2/20 0.39
AGTR1 known ✓ P30556 1/20 0.36
DRD4 known ✓ P21917 1/20 0.35
TLR8 Q9NR97 2/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
FDPS P14324 1/20 0.41
MEN1 O00255 2/20 0.40
LPO P22079 1/20 0.39
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
AGTR2 P50052 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
APLNR P35414 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1782213 0.98 TLR8 (0.43) TLR8KMT2AALDH1A1POLBFDPS
Hydrochloric Acid SCHEMBL2831080 0.98 TLR8 (0.43) TLR8KMT2AALDH1A1POLBFDPS
SCHEMBL40842 0.98 KMT2A (0.46) TLR8KMT2AALDH1A1POLBFDPS
Bromide SCHEMBL204550 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Hydrochloric Acid SCHEMBL28330230 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Iodide SCHEMBL526909 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Bromide SCHEMBL15532009 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Methane SCHEMBL28225457 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Hydrochloric Acid SCHEMBL28021855 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS
Fluoride SCHEMBL15156374 0.96 KMT2A (0.44) TLR8KMT2AALDH1A1POLBFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120138734-A Ionic liquid additive for high-tensile-strength nickel-copper alloy foil and application thereof 九江德福科技股份有限公司 2025-06-13 CN claimed
CN-119677784-A Solvent system and method for processing chitin 海王星纳米技术公司 2025-03-21 CN claimed
US-20240027395-A1 Graphene nanoribbon with nanopore-based signal detection and genetic sequencing technology ACORN GENETICS INC (US) 2024-01-25 US claimed
WO-2024020209-A2 GRAPHENE NANORIBBON WITH NANOPORE-BASED SIGNAL DETECTION AND GENETIC SEQUENCING TECHNOLOGY Acorn Genetics Inc. (US) 2024-01-25 WO claimed
WO-2023178541-A1 METHOD FOR PREPARING 1,2-DICHLOROETHANE 中国科学院大连化学物理研究所 2023-09-28 WO claimed
WO-2023102821-A1 METHOD FOR PREPARING 1,2-DICHLOROETHANE 中国科学院大连化学物理研究所 2023-06-15 WO claimed
CN-112755080-B Villa lipid-lowering pellet and preparation method thereof 海南葫芦娃药业集团股份有限公司 2021-11-19 CN claimed
EP-3117032-B1 FLAME RETARDANT SHAPED OBJECTS MADE FROM CELLULOSE PRODUCED BY A DIRECT SOLUTION PROCESS SMARTPOLYMER GMBH (DE) 2021-07-07 EP claimed
US-10443153-B2 Flame-resistant molded cellulose bodies produced according to a direct dissolving method SMARTPOLYMER GMBH (DE) 2019-10-15 US claimed
US-20170016148-A1 Flame-resistant molded cellulose bodies produced according to a direct dissolving method SMARTPOLYMER GMBH (DE) 2017-01-19 US claimed
WO-2010075232-A1 TUNABLE POLYMER COMPOSITIONS NOVOMER, INC. (US) 2010-07-01 WO claimed
US-20100148126-A1 GENOMIC SEQUENCING USING MODIFIED PROTEIN PORES AND IONIC LIQUIDS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-06-17 US claimed
WO-2010062903-A2 GENOMIC SEQUENCING USING MODIFIED PROTEIN PORES AND IONIC LIQUIDS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-06-03 WO claimed
US-20090259032-A1 METHOD OF PRODUCING CELLULOSE CARBAMATE BLOWN FILM AND USE OF THE SAME FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-15 US claimed
US-20090258227-A1 METHOD OF PRODUCING CELLULOSE CARBAMATE FIBRE AND USE OF THE SAME FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-15 US claimed
US-20090258561-A1 CELLULOSE CARBAMATE SPINNING SOLUTION, METHOD FOR PRODUCING A CELLULOSE CARBAMATE NONWOVEN, AND USE OF THE SAME FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-15 US claimed
US-20080015369-A1 Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels BLUE CUBE IP LLC 2008-01-17 US claimed
US-20050054694-A1 Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions QUEEN'S UNIVERSITY OF BELFAST, THE (GB) 2005-03-10 US claimed
EP-1432512-A1 CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS The Queen's University of Belfast (GB) 2004-06-30 EP claimed
WO-2003028883-A1 CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2003-04-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015369-A1 Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels GK, GLI2, CHLSN KCNH2 968/4885AGTR1 2981/4885DRD4 910/4885
US-20050054694-A1 Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions CEL, KAT5, LEF1 KCNH2 701/4885AGTR1 2458/4885DRD4 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.